Clinic
Yakama Indian Health Center
Yakama Indian Health Center was paid $34.03M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 91% of everything it billed.
33Billing provider infoYAKAMA INDIAN HEALTH CENTER
TOPPENISH, WA 98948
TOPPENISH, WA 98948
33aNPI1528105541assigned 01/31/2007
33bProvider typeFederal Public Health Clinic/Center
28Total paid$34.03M
24GClaims202,624
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,381 | $3.78M | |
| 2019 | 29,803 | $4.03M | |
| 2020 | 22,612 | $3.44M | |
| 2021 | 37,297 | $6.37M | |
| 2022 | 35,220 | $6.74M | |
| 2023 | 28,883 | $5.58M | |
| 2024incomplete | 18,428 | $4.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 91% | 76,920 | 64,868 | $31.09M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.6% | 28,765 | 26,054 | $1.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 8,356 | 7,650 | $413K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,817 | 1,649 | $152K |
| D0140 | Limited oral evaluation - problem focused | <1% | 5,882 | 5,450 | $141K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,108 | 7,300 | $95K |
| D1206 | Topical application of fluoride varnish | <1% | 6,724 | 6,018 | $94K |
| 80050 | General health panel | <1% | 2,268 | 2,085 | $71K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,318 | 992 | $53K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 6,195 | 5,806 | $52K |
| 90686 | <1% | 3,969 | 3,794 | $46K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,028 | 3,723 | $46K |
111 more codes
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 621 | $45K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,410 | $43K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,137 | $36K |
| 0002A | <1% | 941 | $24K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,422 | $24K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 582 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,487 | $23K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 244 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 733 | $19K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 301 | $19K |
| 99441 | <1% | 784 | $19K | |
| D1351 | Sealant - per tooth | <1% | 2,694 | $18K |
| 0001A | <1% | 969 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,135 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 533 | $15K |
| D0330 | Panoramic radiographic image | <1% | 914 | $13K |
| 91320 | <1% | 138 | $12K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 176 | $10K |
| 0004A | <1% | 271 | $10K | |
| 90480 | <1% | 270 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 256 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 248 | $9K |
| 0124A | <1% | 254 | $8K | |
| 80061 | Lipid panel | <1% | 627 | $7K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 86 | $7K |
| 0071A | <1% | 144 | $5K | |
| 90674 | <1% | 337 | $5K | |
| D1110 | Prophylaxis - adult | <1% | 151 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 735 | $4K |
| 0072A | <1% | 106 | $4K | |
| 92015 | Determination of refractive state | <1% | 444 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 859 | $4K |
| 0054A | <1% | 138 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 254 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 41 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 41 | $3K |
| 90678 | <1% | 12 | $3K | |
| 92250 | <1% | 180 | $3K | |
| 99442 | <1% | 87 | $3K | |
| 81025 | <1% | 490 | $3K | |
| D4341 | <1% | 87 | $3K | |
| 98966 | <1% | 222 | $3K | |
| 0012A | <1% | 95 | $3K | |
| 91322 | <1% | 30 | $2K | |
| 90677 | <1% | 12 | $2K | |
| 90715 | <1% | 160 | $2K | |
| D0120 | Dental checkup, returning patient | <1% | 97 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 243 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 137 | $2K |
| 90632 | <1% | 35 | $2K | |
| 90651 | <1% | 273 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 521 | $1K |
| 90688 | <1% | 113 | $1K | |
| 0011A | <1% | 127 | $1K | |
| 81001 | <1% | 486 | $1K | |
| D3221 | <1% | 29 | $1K | |
| 81003 | <1% | 752 | $1K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 524 | $1K |
| 90656 | <1% | 82 | $1K | |
| 90670 | <1% | 64 | $935.53 | |
| D0274 | Bitewings - four radiographic images | <1% | 71 | $908.82 |
| 83655 | <1% | 85 | $903.03 | |
| 90734 | <1% | 205 | $889.96 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 135 | $801.61 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 25 | $792.00 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 16 | $780.33 |
| 0064A | <1% | 17 | $600.00 | |
| 90672 | <1% | 94 | $588.19 | |
| 83718 | <1% | 95 | $579.31 | |
| 86703 | <1% | 39 | $487.06 | |
| 0074A | <1% | 13 | $440.00 | |
| 85014 | <1% | 219 | $424.32 | |
| 85018 | <1% | 220 | $424.00 | |
| 87340 | <1% | 40 | $376.96 | |
| 0031A | <1% | 14 | $369.07 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 39 | $333.22 |
| 86780 | <1% | 26 | $311.65 | |
| 82465 | <1% | 95 | $297.72 | |
| 99188 | <1% | 28 | $291.50 | |
| 86803 | <1% | 38 | $252.08 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 35 | $243.95 |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 12 | $225.50 |
| 86580 | <1% | 43 | $190.40 | |
| 82043 | <1% | 38 | $162.27 | |
| 82570 | <1% | 38 | $140.11 | |
| 87210 | <1% | 25 | $127.52 | |
| 90620 | <1% | 15 | $88.23 | |
| 90647 | <1% | 15 | $83.45 | |
| 90633 | <1% | 12 | $65.57 | |
| 83721 | <1% | 94 | $61.13 | |
| D0460 | <1% | 55 | $38.80 | |
| 90461 | <1% | 12 | $22.71 | |
| D1330 | 0% | 2,171 | $0.00 | |
| 91303 | 0% | 14 | $0.00 | |
| 91307 | 0% | 289 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 61 | $0.00 |
| D9215 | 0% | 37 | $0.00 | |
| 91301 | 0% | 245 | $0.00 | |
| 91305 | 0% | 185 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 19 | $0.00 |
| 91306 | 0% | 17 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 12 | $0.00 |
| 91312 | 0% | 148 | $0.00 | |
| 90662 | 0% | 18 | $0.00 | |
| 91300 | 0% | 2,645 | $0.00 | |
| D0190 | 0% | 963 | $0.00 | |
| D0191 | 0% | 123 | $0.00 | |
| 87806 | 0% | 33 | $0.00 | |
| 96381 | 0% | 16 | $0.00 | |
| D2940 | 0% | 16 | $0.00 | |
| D1120 | Dental cleaning, child | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAMPSON, JAY (CEO)
| Provider | Location | Paid |
|---|---|---|
| White Swan Dental Clnic | White Swan, WA | $238K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.